Can Thermo Fisher Scientific Stock Recover If Markets Fall?

robot
Abstract generation in progress

Thermo Fisher Scientific (TMO) stock has recently fallen by 17.0% due to concerns about its 2026 outlook and a biotech funding slowdown. The article analyzes the stock’s resilience during past economic downturns, including the 2022 Inflation Shock, 2020 Covid Pandemic, 2018 Correction, and 2008 Global Financial Crisis, comparing its performance and recovery time against the S&P 500. It concludes that TMO currently shows weak operational performance and high valuation, making it unattractive, but historically has often been more resilient than the broader market in downturns.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)